| Title | Date | PubMed ID |
|---|
| Characterization of hamster NAD+-dependent 3(17)β-hydroxysteroid dehydrogenase belonging to the aldo-keto reductase 1C subfamily. | 2015 Nov | 26002966 |
| Screening baccharin analogs as selective inhibitors against type 5 17β-hydroxysteroid dehydrogenase (AKR1C3). | 2015 Jun 5 | 25555457 |
| Induction of aldo-keto reductases (AKR1C1 and AKR1C3) abolishes the efficacy of daunorubicin chemotherapy for leukemic U937 cells. | 2014 Sep | 24743520 |
| 2,3-Diarylpropenoic acids as selective non-steroidal inhibitors of type-5 17β-hydroxysteroid dehydrogenase (AKR1C3). | 2013 Apr | 23353746 |
| Synthesis and structure-activity relationships for 1-(4-(piperidin-1-ylsulfonyl)phenyl)pyrrolidin-2-ones as novel non-carboxylate inhibitors of the aldo-keto reductase enzyme AKR1C3. | 2013 Apr | 23454516 |
| Development of potent and selective indomethacin analogues for the inhibition of AKR1C3 (Type 5 17β-hydroxysteroid dehydrogenase/prostaglandin F synthase) in castrate-resistant prostate cancer. | 2013 Mar 28 | 23432095 |
| Pathophysiological roles of aldo-keto reductases (AKR1C1 and AKR1C3) in development of cisplatin resistance in human colon cancers. | 2013 Feb 25 | 23165153 |
| Characterization of rabbit morphine 6-dehydrogenase and two NAD(+)-dependent 3α(17β)-hydroxysteroid dehydrogenases. | 2013 Jan 15 | 23228597 |
| N-Benzoyl anthranilic acid derivatives as selective inhibitors of aldo-keto reductase AKR1C3. | 2012 Sep 15 | 22897946 |
| Selective inhibitors of aldo-keto reductases AKR1C1 and AKR1C3 discovered by virtual screening of a fragment library. | 2012 Sep 13 | 22881866 |